Stay updated on p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.
Latest updates to the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%
- Check10 days agoChange DetectedThe page content and layout appear unchanged between the two screenshots. No new elements or removals are visible.SummaryDifference0.0%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Gastric cancer as a listed condition/MeSH term in the study record. This broadens the documented scope of cancers associated with the trial.SummaryDifference0.0%
- Check31 days agoChange DetectedA new revision tag v3.4.2 was added and the previous government funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check38 days agoChange DetectedAdded an administrative notice about government funding and updated the page revision to v3.4.1; these changes do not affect the trial details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check45 days agoChange DetectedNew items include a glossary toggle, a 'Last Update Submitted that Met QC Criteria' label, and the 'No FEAR Act Data' wording, alongside an updated site revision tag (v3.4.0). The corresponding older items—'Last Update Submitted that met QC Criteria' label, 'No FEAR Act data', and revision tag v3.3.4—were removed.SummaryDifference0.2%
Stay in the know with updates to p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.